NCT01612377View on ClinicalTrials.gov

Long Term Safety Trial of z102 and Prednisone in Patients With Moderate to Severe Rheumatoid Arthritis

PHASE2TerminatedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

September 30, 2013

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Prednisolone-Dipyridamole

Oral, QD

DRUG

Prednisone

Oral QD Prednisone 5mg

DRUG

prednisone

Oral, QD prednisone 7.5mg

Trial Locations (1)

11000

Nemanja Damjanov, Belgrade

Sponsors

Lead Sponsor

Zalicus
All Listed Sponsors
lead

Zalicus

INDUSTRY

NCT01612377 - Long Term Safety Trial of z102 and Prednisone in Patients With Moderate to Severe Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter